| mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |
| mRNA |
SB 216763 |
GDSC1000 |
pan-cancer |
AAC |
0.0038 |
0.9 |
| mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
| mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
| mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.9 |
| mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
| mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
0.9 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
| mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
0.0027 |
0.9 |